Browsing by Author Navasa, Miquel

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 15 of 15
Issue DateTitleAuthor(s)
31-Dec-2012A Gaussia luciferase cell-based system to assess the infection of cell culture- and serum-derived hepatitis C virusKoutsoudakis, George; Pérez del Pulgar Gallart, Sofía; González, Patricia; Crespo, Gonzalo; Navasa, Miquel; Forns, Xavier
5-Sep-2017A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C PatientsCano, Ainara; Mariño, Zoe; Millet Aguilar-Galindo, Òscar; Martínez Arranz, Ibon; Navasa, Miquel; Falcón Pérez, Juan Manuel; Pérez Cormenzana, Miriam; Caballeria Rovira, Joan; Embade, Nieves; Forns, Xavier; Bosch, Jaume; Castro, Azucena; Mato, José M.
Oct-2020Bespoken nanoceria: A new effective treatment in experimental hepatocellular carcinomaFernández Varo, Guillermo; Perramón, Meritxell; Carvajal Romero, Silvia; Oró Bozzini, Denise; Casals, Eudald; Boix i Ferrero, Loreto; Oller, Laura; Macías-Muñoz, Laura; Marfà Bruix, Santiago; Casals, Gregori; Morales Ruiz, Manuel; Casado, Pedro; Cutillas, Pedro R.; Bruix Tudó, Jordi; Navasa, Miquel; Fuster Obregón, Josep; García-Valdecasas Salgado, Juan Carlos; Pavel, Mihai; Puntes, Víctor; Jiménez Povedano, Wladimiro
24-Aug-2011Cell culture replication of a genotype 1b hepatitis C virus isolate cloned from a patient who underwent liver transplantationKoutsoudakis, George; Pérez del Pulgar Gallart, Sofía; Coto Llerena, Mairene; González, Patricia; Dragun, Jakub; Mensa Garrigosa, Laura; Crespo, Gonzalo; Navasa, Miquel; Forns, Xavier
2002Cost-effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.Llovet i Bayer, Josep Maria; Mas, X.; Aponte, John J.; Fuster Obregón, Josep; Navasa, Miquel; Christensen, E.; Rodés, J.; Bruix Tudó, Jordi
7-May-2017Cost-effectiveness of nehanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patientsSoto, Marcelo; Sampietro-Colom, Laura; Lasalvia, Luis; Mira, Aurea; Jiménez Povedano, Wladimiro; Navasa, Miquel
1-Jan-2022Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled studyGómez Bravo, Miguel Ángel; Prieto Castillo, Martín; Navasa, Miquel; Sánchez Antolín, Gloria; Lladó Garriga, Laura; Otero, Alejandra; Serrano, Trinidad; Jiménez Romero, Carlos; García González, Miguel; Valdivieso, Andrés; González Diéguez, María Luisa; Mata, Manuel de la; Pons, José A.; Salcedo, Magdalena; Rodrigo, Juan M.; Cuervas Mons, Valentín; González Rodríguez, Antonio; Caralt, Mireia; Pardo, Fernando; Varo Pérez, Evaristo; Crespo, Gonzalo; Rubin, Ángel; Guilera Sardà, Magda; Aldea, Anna; Santoyo, Julio
28-Aug-2014Genetic variants of innate immune receptors and infections after liver transplantation.Sanclemente, Gemma; Moreno Camacho, Ma. Asunción; Navasa, Miquel; Lozano Soto, Francisco; Cervera, Carlos
24-Oct-2022Impacto de la respuesta viral sostenida en la recurrencia de la hepatitis C tras el trasplante hepáticoMatías Mauro, Ezequiel
27-Dec-2012Interplay between Basic Residues of Hepatitis C Virus Glycoprotein E2 with Vi ral Receptors Neutralizing Antibodies and Lipoproteins.Koutsoudakis, George; Dragun, Jakub; Pérez del Pulgar Gallart, Sofía; Coto Llerena, Mairene; Mensa Garrigosa, Laura; Crespo, Gonzalo; González, Patricia; Navasa, Miquel; Forns, Xavier
2-Oct-2014Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver diseaseMarfà Bruix, Santiago; Crespo Conde, Gonzalo; Reichenbach Marinkovic, Vedrana; Forns, Xavier; Casals Mercadal, Gregori; Morales Ruiz, Manuel; Navasa, Miquel; Jiménez Povedano, Wladimiro
2007MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantationLondoño, María Carlota; Cárdenas Vásquez, Andrés; Guevara, Mónica; Quintó, Llorenç; Heras, Dara de las; Navasa, Miquel; Rimola Castellá, Antonio; García-Valdecasas Salgado, Juan Carlos; Arroyo, Vicente; Ginès i Gibert, Pere
24-Apr-2019Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients.Millán López, Olga; Ruiz, P.; Orts, Lara; Ferré Aparicio, Paula; Crespo, Gonzalo; Santana, Miguel; Fortuna, Virginia; Quintairos Domenech, Luis; Navasa, Miquel; Brunet i Serra, Mercè
1992Portal hypertension in acute liver failureNavasa, Miquel; García Pagán, Juan Carlos; Bosch i Genover, Jaume; Riera, J. R.; Bañares, Rafael; Mas Comas, Ana M.; Bruguera i Cortada, Miquel, 1942-; Rodés, J.
2005Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.Wong, Florence; Bernardi, Mauro; Balk, R.; Christman, B.; Moreau, Richard; Garcia-Tsao, G.; Patch, D.; Soriano Pastor, Germán; Hoefs, J.; Navasa, Miquel